Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 26;9(8):ofac375.
doi: 10.1093/ofid/ofac375. eCollection 2022 Aug.

Clinical Features and Treatment Outcomes of Pulmonary Mycobacterium avium-intracellulare Complex With and Without Coinfections

Affiliations

Clinical Features and Treatment Outcomes of Pulmonary Mycobacterium avium-intracellulare Complex With and Without Coinfections

Grace Wang et al. Open Forum Infect Dis. .

Abstract

Coinfections are more common in patients with cystic fibrosis and bronchiectasis. Infiltrates on imaging studies are seen more commonly in patients with coinfections, but coinfections did not affect treatment outcomes of pulmonary Mycobacterium avium complex.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Flowchart of total health records reviewed and number of patients with pulmonary nontuberculous mycobacteria and pulmonary Mycobacterium avium complex (PMAC) with and without coinfection. Among those who were treated for PMAC, 71 without coinfection and 27 with coinfection had treatment outcome data available. Abbreviations: HIV, human immunodeficiency virus; MAC, Mycobacterium avium complex; PMAC, pulmonary Mycobacterium avium complex; PNTM, pulmonary nontuberculous mycobacteria.
Figure 2.
Figure 2.
Types of coinfections. Pseudomonas, Staphylococcus aureus, and Aspergillus were the most common coinfections.

Similar articles

Cited by

References

    1. Parte AC, Sarda Carbasse J, Meier-Kolthoff JP, Reimer LC, Goker M. List of Prokaryotic Names with Standing in Nomenclature (LPSN) moves to the DSMZ. Int J Syst Evol Microbiol 2020; 70:5607–12. - PMC - PubMed
    1. Johnson MM, Odell JA. Nontuberculous mycobacterial pulmonary infections. J Thorac Dis 2014; 6:210–20. - PMC - PubMed
    1. Griffith DE, Aksamit T, Brown-Elliott BA, et al. . An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175:367–416. - PubMed
    1. Adjemian J, Olivier KN, Seitz AE, Holland SM, Prevots DR. Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries. Am J Respir Crit Care Med 2012; 185:881–6. - PMC - PubMed
    1. Namkoong H, Kurashima A, Morimoto K, et al. . Epidemiology of pulmonary nontuberculous mycobacterial disease, Japan. Emerg Infect Dis 2016; 22:1116–7. - PMC - PubMed